Age 65 and Older
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Age 65 and Older trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Age 65 and Older trials you may qualify forThis feasibility study aims to evaluate the effects of dynamic strength training and isometric strength training on cardiovascular health indicators, mental hea…
This randomized controlled trial aims to evaluate the effectiveness of an individualized Physical Exercise Prescription Program delivered in Primary Care for ad…
The purpose of the study is to learn about how effective, safe, and tolerable the Clostridioides difficile (C. difficile) vaccine is in decreasing the number of…
Reduce inappropriate antibiotic use is a priority of public health agencies. Community-acquired pneumonia (CAP) is one of the most important indications for ant…
The goal of this phase IV, open-label, randomized clinical trial is to evaluate whether intravenous iron improves quality of life in adults aged 65 years and ol…
This study will compare three different versions of the Pericapsular Nerve Group (PENG) block in adults aged 65 years and older who are undergoing surgery for h…
The prospective cost-effectiveness (cost-utility) analysis from the perspective of the Canadian public healthcare system was completed in 2021. Health state uti…
The primary objective is to evaluate the effectiveness of combining action observation with a therapeutic exercise program to improve balance and prevent falls…
Physical inactivity increases substantially after age 60 and represents a major public health challenge in older adults, as it is linked to increased risk of fu…